• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBioNTech

BioNTech

Page 2 of 6
Structural images of the main COVID-19 virus variants from Alpha to Omicron.
HealthBioNTech and London A.I. firm create ‘early warning system’ to spot dangerous new COVID-19 variants before they spread
By Jeremy KahnJanuary 12, 2022
Photo illustration of a syringe jabbing a stock chart that shows shares rising and then falling
FinanceOmicron is upping booster jab demand. So why are COVID vaccine makers’ shares tanking?
By Jeremy KahnDecember 29, 2021
A health care worker prepares a Moderna booster vaccine dose.
HealthModerna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
By David MeyerDecember 27, 2021
COVID-19 vaccine in front of Israeli flag
HealthIsrael to give fourth COVID vaccine doses to combat Omicron, despite lack of data on second boosters
By David MeyerDecember 22, 2021
HealthEurope taps Pfizer and BioNTech to provide 180 million more vaccines to face ‘ferocious’ Omicron threat
By Christiaan HetznerDecember 17, 2021
HealthJ&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
By BloombergDecember 17, 2021
HealthA desperate Germany turns to vaccine-hesitant Eastern Europe for COVID jabs
By Christiaan HetznerDecember 16, 2021
A soldier in Switzerland prepares vaccine doses.
HealthGermany’s new health minister delivers a bombshell: The country doesn’t have enough COVID-19 vaccines
By Christiaan HetznerDecember 15, 2021
NewslettersThe world’s most sought after vaccine is still blocked in China
By Grady McGregor and Eamon BarrettDecember 14, 2021
HealthPfizer and BioNTech say booster dose is necessary to fight Omicron variant
By Naomi Kresge and BloombergDecember 8, 2021
HealthPfizer’s vaccine has a ‘robust, but not complete’ loss of immune protection against Omicron, tests show
By Antony Sguazzin, Jason Gale and BloombergDecember 7, 2021
A health worker speaks with a patient in the reception area of a Testaro Covid-19 testing site in the Goodwood district of Cape Town, South Africa,
HealthOmicron vaccine to begin clinical trial in South Africa
By Jeremy KahnDecember 6, 2021
HealthPfizer-BioNTech and Moderna jabs perform best in study of COVID booster vaccines
By Suzi Ring, Irina Anghel and BloombergDecember 3, 2021
HealthGlobal drugmakers could roll out Omicron-adapted COVID vaccines in 100 days
By Yvonne LauNovember 29, 2021
HealthPfizer’s COVID-19 vaccine generated the strongest immune response in study of 4 jabs
By Jason Gale and BloombergNovember 15, 2021
1
  • 1
  • 2
  • 3
  • 4
  • 5
6
Most Popular
C-Suite
OpenAI’s Sam Altman says his highly disciplined daily routine has ‘fallen to crap’—and now unwinds on weekends at a ranch with no cell phone serviceAn image of a popular article
By Jacqueline MunisFebruary 5, 2026
Politics
Meet the Palm Beach billionaire who paid $2 million for a private White House visit with TrumpAn image of a popular article
By Tristan BoveFebruary 3, 2026
Travel & Leisure
How Japan replaced France as the country young Americans obsessively romanticize—they’re longing for civility they don’t see at homeAn image of a popular article
By Nick LichtenbergFebruary 5, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.